VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,660,000 | +46.3% | 243,341 | 0.0% | 0.03% | +45.0% |
| Q1 2018 | $3,870,000 | -28.2% | 243,341 | -5.5% | 0.02% | -16.7% |
| Q4 2017 | $5,387,000 | +46.2% | 257,625 | 0.0% | 0.02% | +26.3% |
| Q3 2017 | $3,685,000 | -18.8% | 257,625 | -1.5% | 0.02% | -13.6% |
| Q2 2017 | $4,539,000 | +57.6% | 261,532 | 0.0% | 0.02% | +57.1% |
| Q1 2017 | $2,880,000 | -43.4% | 261,532 | 0.0% | 0.01% | -48.1% |
| Q4 2016 | $5,092,000 | -41.8% | 261,532 | -26.7% | 0.03% | -35.7% |
| Q3 2016 | $8,756,000 | +4.1% | 356,657 | -15.0% | 0.04% | -2.3% |
| Q2 2016 | $8,414,000 | -20.9% | 419,391 | +3.8% | 0.04% | -29.5% |
| Q1 2016 | $10,637,000 | -73.8% | 404,008 | 0.0% | 0.06% | -74.7% |
| Q4 2015 | $40,611,000 | -43.4% | 404,008 | 0.0% | 0.24% | -45.6% |
| Q3 2015 | $71,785,000 | -24.6% | 404,008 | -5.8% | 0.44% | -15.3% |
| Q2 2015 | $95,180,000 | +12.5% | 428,754 | 0.0% | 0.52% | +16.0% |
| Q1 2015 | $84,619,000 | +37.9% | 428,754 | 0.0% | 0.45% | +37.5% |
| Q4 2014 | $61,359,000 | – | 428,754 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |